Clinical trial
A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects.
NCT00141934 · Sosei, Industry · Completed
Key facts
| NCT number | NCT00141934 |
|---|---|
| Title | A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects. |
| Official title | Phase II Randomised, Double-Blind, Multicentre, Placebo-Controlled, Dose-Ranging, Parallel Group Study to Compare the Efficacy, Safety and Tolerability of 3 Strengths of AD 452 in Adults With Active RA Who Are Currently Taking Methotrexate. |
| Lead sponsor | Sosei, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | AD 452 |
| Enrollment | 232 |
| Start date | Aug 1, 2005 |
| First posted | Sep 2, 2005 |
| Last update posted | Apr 5, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: